Loading...
Ingevity Corp (NGVT) is not a strong buy for a beginner investor with a long-term focus at this time. The company's financial performance has been weak, with significant declines in revenue, net income, and EPS in the latest quarter. Technical indicators are mixed, with bearish MACD and neutral RSI, though moving averages are bullish. Options data shows low put-call ratios, indicating limited bearish sentiment, but there is no strong signal for upward momentum. Analysts are neutral, and there are no recent news or significant positive catalysts to drive the stock higher. For a long-term investor, it is better to wait for clearer signs of financial recovery or stronger growth opportunities.
The MACD is bearish with a histogram of -0.07, indicating a downward trend. RSI is neutral at 44.286. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the pivot level of 73.721, with key support at 70.772 and resistance at 76.67. The stock has a 70% chance of declining in the next week and month, based on historical patterns.

The company plans to focus on its core platforms in the activated carbon Performance Materials and Paving Tech segments. Management aims to reduce debt and return 15% to shareholders through buybacks over the next two years.
Weak financial performance in Q3 2025, with revenue, net income, and EPS all declining significantly year-over-year. No recent news or significant trading trends from insiders or hedge funds. Analysts remain neutral, citing uncertainty due to ongoing business divestitures.
In Q3 2025, revenue dropped by -0.21% YoY to $333.1M. Net income fell by -140.58% YoY to $43.5M, and EPS declined by -140% YoY to 1.18. Gross margin improved slightly to 40.2%, up 1.98% YoY.
Analysts are neutral on NGVT. Wells Fargo raised the price target to $65 but remains cautious due to uncertainty around business divestitures. BMO Capital raised the price target to $70 and is optimistic about the company's focus on core platforms and shareholder returns.